Combination therapy for inoperable ileal gastrointestinal stromal tumour

被引：0
作者：
Zhao, Wei [1 ,2 ]
Deng, Jingyu [1 ,2 ]
Sun, Lin [2 ,3 ]
Sun, Yan [2 ,3 ]
Liang, Han [1 ,2 ]
机构：
[1] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Dept Gastr Canc Surg, Tianjin, Peoples R China
[2] Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China
[3] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Dept Pathol, Tianjin, Peoples R China
来源：
ANZ JOURNAL OF SURGERY | 2021年 / 91卷 / 05期
关键词：
PROGNOSTIC-FACTORS; IMATINIB; MANAGEMENT;
D O I：
10.1111/ans.16382
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：E346 / E349
页数：4
相关论文
共 7 条
  • [1] Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib - Analysis of prognostic factors (EORTC-STBSG collaborative study)
    Bauer, S.
    Rutkowski, P.
    Hohenberger, P.
    Miceli, R.
    Fumagalli, E.
    Siedlecki, J. A.
    Nguyen, B. -P.
    Kerst, M.
    Fiore, M.
    Nyckowski, P.
    Hoiczyk, M.
    Cats, A.
    Casali, P. G.
    Treckmann, J.
    van Coevorden, F.
    Gronchi, A.
    [J]. EJSO, 2014, 40 (04): : 412 - 419
  • [2] Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 29, pg 68, 2018)
    Casali, P. G.
    Abecassis, N.
    Aro, H. T.
    Bauer, S.
    Biagini, R.
    Bielack, S.
    Bonvalot, S.
    Boukovinas, I.
    Bovee, J. V. M. G.
    Brodowicz, T.
    Broto, J. M.
    Buonadonna, A.
    De Alava, E.
    Tos, A. P. Dei
    Del Muro, X. G.
    Dileo, P.
    Eriksson, M.
    Fedenko, A.
    Ferraresi, V.
    Ferrari, A.
    Ferrari, S.
    Frezza, A. M.
    Gasperoni, S.
    Gelderblom, H.
    Gil, T.
    Grignani, G.
    Gronchi, A.
    Haas, R. L.
    Hassan, B.
    Hohenberger, P.
    Issels, R.
    Joensuu, H.
    Jones, R. L.
    Judson, I.
    Jutte, P.
    Kaal, S.
    Kasper, B.
    Kopeckova, K.
    Krakorova, D. A.
    Le Cesne, A.
    Lugowska, I.
    Merimsky, O.
    Montemurro, M.
    Pantaleo, M. A.
    Piana, R.
    Picci, P.
    Piperno-Neumann, S.
    Pousa, A. L.
    Reichardt, P.
    Robinson, M. H.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 267 - 267
  • [3] Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor
    Li, Jian
    Ye, Yingjiang
    Wang, Jian
    Zhang, Bo
    Qin, Shukui
    Shi, Yingqiang
    He, Yulong
    Liang, Xiaobo
    Liu, Xiufeng
    Zhou, Ye
    Wu, Xin
    Zhang, Xinhua
    Wang, Ming
    Gao, Zhidong
    Lin, Tianlong
    Cao, Hui
    Shen, Lin
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2017, 29 (04) : 281 - 293
  • [4] National Comprehensive Cancer Network, 2019, NCCN GUID SOFT TISS
  • [5] Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors
    Raut, Chandrajit P.
    Posner, Matthew
    Desai, Jayesh
    Morgan, Jeffrey A.
    George, Suzanne
    Zahrieh, David
    Fletcher, Christopher D. M.
    Demetri, George D.
    Bertagnolli, Monica M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (15) : 2325 - 2331
  • [6] Initial and late resistance to imatinib in advanced gastrointestinal stromal. tumors are predicted by different prognostic factors: A European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group study
    Van Glabbeke, M
    Verweij, J
    Casali, PG
    Le Cesne, A
    Hohenberger, P
    Ray-Coquard, I
    Schlemmer, M
    van Oosterom, AT
    Goldstein, D
    Sciot, R
    Hogendoorn, PCW
    Brown, M
    Bertulli, R
    Judson, IR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) : 5795 - 5804
  • [7] Safety and efficacy of imatinib (ST1571) in metastatic gastrointestinal stromal tumours: a phase I study
    van Oosterom, AT
    Judson, I
    Verweij, J
    Stroobants, S
    di Paola, ED
    Dimitrijevic, S
    Martens, M
    Webb, A
    Sciot, R
    Van Glabbeke, M
    Silberman, S
    Nielsen, OS
    [J]. LANCET, 2001, 358 (9291) : 1421 - 1423
1